Article
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Oncogene - 22 Nov 2012
Kumar S M, Liu S, Lu H, Zhang H, Zhang P J, Gimotty P A, Guerra M, Guo W, Xu X
Abstract excerpt
There is enormous interest to target cancer stem cells (CSCs) for clinical treatment because these cells are highly tumorigenic and resistant to chemotherapy. Oct4 is expressed by CSC-like cells in different types of cancer. However, function of Oct4 in tumor cells is unclear. In this study, we showed that expression of Oct4 gene or transmembrane delivery of Oct4 protein promoted dedifferentiation of melanoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
